首页 | 本学科首页   官方微博 | 高级检索  
   检索      

降纤酶联合尼莫地平治疗椎基底动脉系TIA30例分析
引用本文:付留长,张举孔,等.降纤酶联合尼莫地平治疗椎基底动脉系TIA30例分析[J].蛇志,2001,13(3):15-16.
作者姓名:付留长  张举孔
作者单位:付留长(河南省南阳市第二人民医院神经内科,河南,南阳,473012)       张举孔(河南省南阳市第二人民医院神经内科,河南,南阳,473012)       任文(河南省南阳市第二人民医院神经内科,河南,南阳,473012)
摘    要:目的:观察降纤酶联合尼莫地平对椎基底动脉系一过氧缺血(TIA)发作的疗效。方法:将60例椎基底动脉系TIA患者随机分为降纤酶加尼莫地平治疗组和培他啶对照组各30例。结果:治疗组治疗后第1天、第3天终止发控制率分别为60.3%和90%,均显著高于对照组的16.6%和50%(P<0.01)。治疗组治疗后血液粘度及纤维蛋白原明显降低。结论:降纤酶联合尼莫地平治疗椎基底动脉系TIA有良好的疗效,对预防其进展及脑梗死有明显的作用。

关 键 词:降纤酶  尼莫地平  椎基底动脉系一过氧缺血  培他啶  治疗
文章编号:1001-5639(2001)03-0015-02
修稿时间:2001年5月22日

Analysis of Defrinogenase Combing Nimodipine to 30 Cases of Vertebrobasilar Arterial TIA
FU Liu chang,ZHANG Ju kong,REN Wen.Analysis of Defrinogenase Combing Nimodipine to 30 Cases of Vertebrobasilar Arterial TIA[J].Journal of Snake,2001,13(3):15-16.
Authors:FU Liu chang  ZHANG Ju kong  REN Wen
Abstract:Objective Toinvestigate the effectiveness of defrinogenase combining nimodipine to vertebrobasilar arterial TIA Methods 60 vertebrobasilar arterial TIA patients were randomly divided into defrinogenase combining nimodipine group(n=30) and betahistini control group(n=30) Result In group of defrinogenase,the first and third day episode control ratios were 60 3% and 90% respectively Both were higher than the control group 16 6% and 50%(P<0 01) Significanty Aftertreatment the blood viscosity and fibrinegen of defrinogenase group decreased significanty Conclusion Defrinogeanse combining nimodipine xould treat vertebrbasilar arthrial TIA effectly and prevent it from deteriorating to cerebral infarction
Keywords:defrinogenase  nimodipine  vertebrobasilar artery  betahistini
本文献已被 CNKI 维普 等数据库收录!
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号